System for user interaction around a common computer game objective

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Zynga Inc. patent solves the following problem:

In many computer games, there is a virtual world or the other thought to play a place where a player / user control the game with one or more player characters (in this attitude, player attributes, or PC ). A game engine receives inputs from the player, determine the player character, determine the outcome of events and presents the player with a display match ag what happened. In some games, there are many players, online or in a single console, where each player controls one or more player characters.

Our analysis of this patent is as follows:

Zynga Inc.’s patent US 9457278 B2 deals with System for user interaction around a common computer game objective.
A computer-implemented method comprises identifying a user to a computer-implemented game to contend with an additional user in the pursuit of a common goal game. The recognition was based at least partially on the user is not directly related, found in the relationship data, with further user. Interactions, in the computer-implemented game, among the more user and user to pursue common game goal computer-implemented game could responsive to their users.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Sequestration and release of carbon dioxide

File for Quick & Easy Patent Protection with PowerPatent.

The The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin patent solves the following problem:

Our analysis of this patent is as follows:

The Provost, Fellows, Foundation Scholars, And The Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin’s patent US 9457312 B2 deals with Sequestration and release of carbon dioxide.
A strategy for change capture and release carbon dioxide contained in the steps of providing a solution to a defined tetranuclear complex or mixture thereof, the adsorption sites given in coordination with solvent molecules such as water molecules. The solution is contained in the atmosphere or in a gas stream containing carbon dioxide to sequester carbon dioxide, and the pH of the resulting reaction mixture was adjusted to facilitate the release of carbon dioxide. The solution used to sequester carbon dioxide is a solution to a polynuclear transition metal compound with the formula: (I) and the tetranuclear transition metal compound that sequestered carbon dioxide is the formula: (II).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Method for determining whether a point lies along a curve in a multidimensional space

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Yandex Europe Ag patent solves the following problem:

In many applications in the computer, the data can be represented by a curve through the two or more levels of a multi-dimensional space, the second data may represent a point in the same multi dimensional space, and it is useful to determine the points represent the second data lies along the curve representative of the first data. For example, the first data to be represented in some way in all the land in a geographic region, and the second data that represents an estimated position of a vehicle within the geographic region, may be obtained from a global positioning system (GPS) satellite. In such cases, it may be useful to determine if the vehicle were on the way, for example to evaluate whether the driver of the car should be told either to continue in some way or correction way.

Our analysis of this patent is as follows:

Yandex Europe Ag’s patent US 9459095 B2 deals with Method for determining whether a point lies along a curve in a multidimensional space.
There is disclosed a computer-implemented method for determining whether a point lies along a curve in a multi-dimensional space and program instructions executable to perform procedures. The methods include the value of the first curve coordinates defining each one in a position and a form of the first curve in multi-dimensional space; recognition of the regional multi-dimensional space each containing a respective portion of the first curve while creating a second curve once the first curve; and storing, in a non-transitory computer-readable medium, region coordinates at least one of the region; where an analysis of the region coordinates and point coordinates defining a position of point to multi-dimensional space is executable to provide a user with an indication of the points lie along the first curve or an indication that the point does not lie along the first curve. The other implementing comprising performing said analysis and said give signs.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Antibody induced cell membrane wounding

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Igm Biosciences, Inc. patent solves the following problem:

Cell membrane wounding is a disruption in the plasma membrane of cells, and in general a surviving the incident. Cell membrane strike is a common occurrence in mammal mechanically active tissues such as endothelial lining of the aorta or the gastrointestinal tract, skin epithelia or myocytes in the heart or skeletal muscles, and also shown during the invasion of cells in trypanosomes. In laboratory conditions, cell wounding normally induced using mechanical means to bind to the cell membrane, such as using a Microneedle to penetrate the plasma membrane or by scratching a culture dish to differentiate one part of a cell.

Our analysis of this patent is as follows:

Igm Biosciences, Inc.’s patent US 9458241 B2 deals with Antibody induced cell membrane wounding.
Compositions and methods for inducing cell membrane wounding, cell permeabilization and cell death gave. The composition comprises a polyvalent agent that binds to a highly expressed cell surface antigen present on the surface of a cell. At best, the cell surface antigen with the cell cytoskeleton. A preferred polyvalent agent is an IgM, and enhanced cell wounding and murder will be given to the addition of a crosslinking agent. Sublethal concentration in vivo, the cell wounding antibody permeabilize cells and dramatically improve the response to chemotherapeutic agents, even in patients rebelled chemotherapeutic agents.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Children’s Medical Corporation patent solves the following problem:

Drug permeability and half-life are some of the limiting factors in the development of new therapeutics. This is useful to have developed ways to improve upon the drug, indicating that drug to the cells and their long half-life.

Our analysis of this patent is as follows:

Children’s Medical Corporation’s patent US 9457097 B2 deals with Mucosal delivery of therapeutic molecules, proteins, or particles coupled to ceramide lipids.
Described in these compositions and methods useful to allow for absorption (passage) of the agent of interest, such as therapeutic agents, across the epithelial and mucosal barrier and / or certain subcellular compartment of the cell, as to recycling endosome (RE), Golgi and endoplasmic reticulum (ER).

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Structure for preventing air leakage and air cleaner having the same

Apply for Patent – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Coway Co., Ltd, , Winix Inc. patent solves the following problem:

In general, an air cleaner is a device for drawing in contaminated indoor air and dust, odor-causing particulates, and the like, to purify contaminated indoor air be clean air. The pure air is discharged into the outside air cleaner and an indoor place.

Our analysis of this patent is as follows:

Coway Co., Ltd, , Winix Inc.’s patent US 9457309 B2 deals with Structure for preventing air leakage and air cleaner having the same.
There was an air leakage control structure and an air cleaner with the same. The air leakage control structure includes: a partition unit with an inlet opening formed in a portion of it to allow air to be introduced therethrough and a rib formed protruding from the circumference mouth open; an air blowing fan unit with partition and rotating to allow air to be introduced through the inlet openings; a motor unit connected to the air blowing fan to turn the air blowing fan; and an air guidance units connected to the ribs formed protruding from the unit partition to form an outlet opening, and prevent air leakage when the wind introduced through the net open flowing through the outlet opening.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Unlocking virtual items in a virtual space responsive to physical token detection

Patent Registration – Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Disney Enterprises, Inc. patent solves the following problem:

Conventionally, various virtual objects in a virtual space can be obtained. Such access, however, will be mostly based on a stage or in the completion of the gameplay in the virtual space. For example, a videogame, a given virtual object can be accessed responsive to a user to attain a level of gameplay. Moreover, for a given character, in particular virtual things shall be limited to the virtual objects belonging to the given character.

Our analysis of this patent is as follows:

Disney Enterprises, Inc.’s patent US 9457263 B2 deals with Unlocking virtual items in a virtual space responsive to physical token detection.
Virtual goods can be unlocked in a virtual space responsive to the physical mark detection. A common virtual object repository can be given in virtual space. Once unlocked, in a given virtual object can be accessible to many characters in the virtual space by the virtual object repository. Dry in a virtual space can be held. customization can be based on virtual goods accessible by the virtual object repository.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Immunomedics, Inc. patent solves the following problem:

For many years it was a goal of scientists in the field of specifically targeted drug therapy using monoclonal antibodies (mAbs) for the specific delivery of toxic agents in human cancers. Conjugates of tumor-associated mAbs and suitable toxic agents developed, but have had mixed success in cancer therapy in humans, and virtually no application in other diseases, such as infectious and autoimmune diseases. The toxic agent is most often a chemotherapeutic drug, although particle-emitting radionuclides, or bacterial or plant toxins, also within the framework of mAbs, especially for cancer therapy (Sharkey and Goldenberg, CA Cancer J Clin. 2006 July-Aug.; 56 (4): 226-243) and, more recently, with radioimmunoconjugates for preclinical therapy of certain infectious diseases (Dadachova and Casadevall, QJ Nucl Med mol Imaging 2006; 50 ( 3): 193-204).

Our analysis of this patent is as follows:

Immunomedics, Inc.’s patent US 9458242 B2 deals with Dosages of immunoconjugates of antibodies and SN-38 for improved efficacy and decreased toxicity.
The present invention relates to therapeutic immunoconjugates comprising SN-38 attached to an antibody or antigen-binding antibody fragments. antibody can bind to the EGP-1 (TROP-2), CEACAM5, CEACAM6, CD74, CD19, CD20, CD22, CSAP, hľa-DR, or AFP MUC5ac and the immunoconjugate can be administered at a dose between 4 mg / kg and 24 mg / kg, preferably 4, 6, 8, 9, 10, 12, 16 or 18 mg / kg. When administered in specified dosages and schedules, the immunoconjugate could reduce solid tumor size, reduce or eliminate metastases and effective to treat cancer resistant to standard therapies, such as radiation therapy, chemotherapy or immunotherapy.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Dispensing device with displacement detection

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time for Utility, Provisional or Design Patent Creation with PowerPatent software and services.

The Abiogenix Inc. patent solves the following problem:

Healthcare is implemented as an open-loop system. Patients diagnosed with a doctor and prescribed treatment. However, there are not many reliable systems to be able to monitor if patients comply with or follow the instructions given by the doctor. Studies show that when patients stop taking their medication for three days, they are unlikely to continue their regimen.

Our analysis of this patent is as follows:

Abiogenix Inc.’s patent US 9456959 B2 deals with Dispensing device with displacement detection.
Embodiments generally relate to a pill box adapted to provide treatment. In one embodiment, the pill box includes a base member, a carousel with a base member and configured to rotate about the base, one or more chambers, each chamber formed in carousel and configured to store a single dose of medication with a lid configured to enclose the base and the carousel. The pill box ratchet growth mechanism includes a strong member and a stop member configured to perform motion carousel in a first direction and to restrict motion in a second direction, and a locking component configured to allow a pre-determined eviction ACCOUNT in the first direction and to limit further displacement in the first direction by locking the carousel.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with PowerPatent’s Utility, Provisional or Design Patent Filing Software

The Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet), , Universidad Catolica De Cordoba, , Assistance Pubuque Hopitaux De Paris, , Universite Pierre Et Marie Curie (Paris 8) patent solves the following problem:

The present invention relates to compositions and methods for delivering therapeutic agents to a subject in need thereof using the polypeptide carriers. Particularly, the present invention relates to polypeptides such as Giardia sp. variable surface proteins (VSPs) that act as carriers for delivery of therapeutic agents such as bioactive peptides.

Our analysis of this patent is as follows:

Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet), , Universidad Catolica De Cordoba, , Assistance Pubuque Hopitaux De Paris, , Universite Pierre Et Marie Curie (Paris 8)’s patent US 9457096 B2 deals with Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery.
invention provides compositions for oral delivery and methods of treatment using the VSP carriers, such as Giardia sp. variable surface protein (VSP) to deliver therapeutic agents. VSP drug carriers can be combined with bioactive peptides, eg, insulin, glucagon, or hGH, and administered orally or mucosally. VSP carriers resistant to acidic pHs and proteolytic degradation and protect the therapeutic agent from the breakdown in the gastrointestinal tract.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.